{"DataElement":{"publicId":"6113723","version":"1","preferredName":"Breast Carcinoma Sentinel Lymph Node Largest Metastasis Diameter Measurement","preferredDefinition":"Numeric annotation to indicate the largest diameter of sentinel lymph node metastases measured in mm.","longName":"BRCA_SLN_LRG_METS_DIAM_MSRMT","context":"CCTG","contextVersion":"1","DataElementConcept":{"publicId":"6113699","version":"1","preferredName":"Breast Carcinoma Sentinel Lymph Node Largest Metastasis Diameter","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla._Greatest in size of those under consideration._The first lymph node that is affected by cancer spread from the primary site.  Sentinel lymph node biopsy is part of the staging work-up to determine early metastasis to regional lymph nodes in patients with breast carcinoma or melanoma._The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor._The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.","longName":"6113697v1.0:3793746v1.0","context":"CCTG","contextVersion":"1","ObjectClass":{"publicId":"6113697","version":"1","preferredName":"Breast Carcinoma Sentinel Lymph Node","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.:The first lymph node to which cancer is likely to spread from the primary tumor. Cancer cells may appear first in the sentinel node before spreading to other lymph nodes.","longName":"C4872:C12947","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sentinel Lymph Node","conceptCode":"C12947","definition":"The first lymph node that is affected by cancer spread from the primary site.  Sentinel lymph node biopsy is part of the staging work-up to determine early metastasis to regional lymph nodes in patients with breast carcinoma or melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D24FDC-18A4-68D2-E053-F662850A5FF7","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"ONEDATA","dateModified":"2018-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3793746","version":"1","preferredName":"Largest Metastasis Diameter","preferredDefinition":"Greatest in size of those under consideration.:Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer.:Diameter; the length of a straight line passing through the center of a circle and connecting two points on the circumference.","longName":"C25550:C19151:C25285","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Largest","conceptCode":"C25550","definition":"Greatest in size of those under consideration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diameter","conceptCode":"C25285","definition":"The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E000DB7A-9434-9ACC-E040-BB89AD4365BE","latestVersionIndicator":"Yes","beginDate":"2013-06-25","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-06-25","modifiedBy":"ONEDATA","dateModified":"2013-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D24FDC-18B2-68D2-E053-F662850A5FF7","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeDescription":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6113695","version":"1","preferredName":"Millimeter Measurement","preferredDefinition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","longName":"6113695v1.0","context":"CCTG","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"mm","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"1","format":"99.9","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184312","version":"1","preferredName":"Measurement","preferredDefinition":"Measurement; the size or magnitude of something.","longName":"C25209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"DB6C8AC6-1DB1-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"DWARZEL","dateModified":"2006-10-26","changeDescription":"Move to caBIG context as teh preferred Rep class for Measurement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D24FDC-1885-68D2-E053-F662850A5FF7","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeDescription":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"BRCA_SLN_LRG_METS_DIAM_MSRMT","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"Measurement of largest metast","type":"Preferred Question Text","description":"Measurement of largest metastases","url":null,"context":"CCTG"}],"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D31806-1378-5AE4-E053-F662850A532E","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeDescription":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}